DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+3.14%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.82B
AUM Growth
+$2.82B
(+11%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
5.92%
Top 10 Holdings %
Top 10 Hldgs %
31.06%
Holding
130
New
28
Increased
28
Reduced
22
Closed
14
Top Buys
| 1 |
Q32 Bio
QTTB
|
$97.7M |
| 2 |
Centene
CNC
|
$62.8M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$41.3M |
| 4 |
CVS Health
CVS
|
$34.2M |
| 5 |
GSK
GSK
|
$31.6M |
Top Sells
| 1 |
DexCom
DXCM
|
$65.6M |
| 2 |
Glaukos
GKOS
|
$52.4M |
| 3 |
Insulet
PODD
|
$46.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$35.8M |
| 5 |
McKesson
MCK
|
$34.5M |
Sector Composition
| 1 | Healthcare | 76.69% |
| 2 | Financials | 1.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
VYNE Therapeutics
VYNE
$8.09M
| $16M | 0.56% |
+426,749
| New | +$16M |
|
|
CBAY
52
DELISTED
Cymabay Therapeutics
CBAY
| $15.8M | 0.55% |
+1,213,181
| New | +$15.8M |
|
|
53
Insulet
PODD
$24.2B
| $14.8M | 0.51% |
171,000
-534,573
| -76% | -$46.3M |
|
54
eHealth
EHTH
$126M
| $14.8M | 0.51% |
1,030,802
+16,886
| +2% | +$242K |
|
|
GTHX
55
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $13.8M | 0.48% |
+373,000
| New | +$13.8M |
|
56
Molina Healthcare
MOH
$9.6B
| $13.6M | 0.47% |
168,000
-400,000
| -70% | -$32.5M |
|
|
IMMU
57
DELISTED
Immunomedics Inc
IMMU
| $13.6M | 0.47% |
930,448
-370,000
| -28% | -$5.41M |
|
58
Zimmer Biomet
ZBH
$20.8B
| $13.2M | 0.46% |
+121,000
| New | +$13.2M |
|
59
Ardelyx
ARDX
$1.57B
| $13.1M | 0.46% |
2,602,733
+133,153
| +5% | +$672K |
|
60
Galapagos
GLPG
$2.06B
| $13M | 0.45% |
130,000
| – | – |
|
61
Synlogic
SYBX
$17.4M
| $12.8M | 0.44% |
1,365,143
+515,000
| +61% | +$4.83M |
|
|
WMGI
62
DELISTED
Wright Medical Group Inc
WMGI
| $12.6M | 0.44% |
+634,000
| New | +$12.6M |
|
63
Rhythm Pharmaceuticals
RYTM
$6.75B
| $11.6M | 0.4% |
582,010
| – | – |
|
|
SCTL
64
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $11.1M | 0.39% |
1,010,000
-891,685
| -47% | -$9.82M |
|
65
Wave Life Sciences
WVE
$1.27B
| $10.8M | 0.37% |
268,174
-46,500
| -15% | -$1.86M |
|
|
PFNX
66
DELISTED
Pfenex Inc.
PFNX
| $9.96M | 0.35% |
1,659,501
+829,285
| +100% | +$4.98M |
|
|
IVTY
67
DELISTED
Invuity, Inc
IVTY
| $9M | 0.31% |
2,336,889
+1,159,660
| +99% | +$4.46M |
|
|
NVTA
68
DELISTED
Invitae Corporation
NVTA
| $8.92M | 0.31% |
1,901,788
+178,788
| +10% | +$838K |
|
|
RETA
69
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $8M | 0.28% |
390,000
| – | – |
|
70
Option Care Health
OPCH
$4.7B
| $7.69M | 0.27% |
3,124,000
| – | – |
|
71
Regenxbio
RGNX
$498M
| $7.65M | 0.27% |
256,300
| – | – |
|
72
Rocket Pharmaceuticals
RCKT
$358M
| $7.5M | 0.26% |
+400,000
| New | +$7.5M |
|
|
ALPN
73
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $7.31M | 0.25% |
913,100
| – | – |
|
|
NEOS
74
DELISTED
Neos Therapeutics, Inc
NEOS
| $7.18M | 0.25% |
864,906
+119,139
| +16% | +$989K |
|
|
ARMO
75
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $7.05M | 0.24% |
+188,525
| New | +$7.05M |
|